Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
2021-12-23 07:44
Deargen Annonuces Patent Application for a TNBC Target Novel Drug Candidate Using AI
2021-12-22 22:00
AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in Congenital Myotonic Dystrophy
2021-12-22 21:00
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines
2021-12-22 19:00
TCM provides new alternatives for the fight against COVID-19
2021-12-22 10:15
Jolly Good develops a medical VR filming system exclusively for ambulances with physicians
2021-12-21 21:00
Hanjiao Group Invited by Rising China Interview Show
2021-12-21 20:30
Henlius' anti-PD-1 mAb MRCT achieved 15.38 months OS in first-line treatment of SCLC, reducing the risk of death by 38% of the overall population
2021-12-20 22:00
I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization
2021-12-20 21:00
First Patient Dosed in Australia in ATG-101 First-in-Human Trial
2021-12-20 10:56
ZEPP HEALTH REPORTS SURGE IN GLOBAL SHIPMENTS IN Q3 2021
2021-12-17 23:00
Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma
2021-12-17 20:00
Launching the world's first all-in-one medical and welfare VR platform JOLLYGOOD+
2021-12-16 21:00
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency
2021-12-16 21:00
Gracell Biotechnologies Selected for Addition to NASDAQ Biotechnology Index
2021-12-16 21:00
Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia
2021-12-16 21:00
Senhwa Clinical Data Abstract for Silmitasertib in Patients with Advanced Basal Cell Carcinoma Accepted for 2022 AAD Annual Meeting
2021-12-16 20:00
Akso Health Group Announces Effective Date of Name Change and Ticker Symbol Change
2021-12-16 19:00
Bionomics Limited Announces Pricing of Initial Public Offering in the United States
2021-12-16 19:00
Health insurance "bargaining": Every cent for life and health
2021-12-16 17:22
1
182
183
184
185
186
801